Catalyst Wire Dossier Catalyst Wire Dossier

IBER

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBER, covering 2019-08-26 to 2019-08-26. Get the full timeline:

Most recent: Clinical Trial Update: IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL [Phase 2]

See pricing